Logo image of NXI.PA

NEXITY (NXI.PA) Stock Fundamental Analysis

EPA:NXI - Euronext Paris - Matif - FR0010112524 - Common Stock - Currency: EUR

11  +0.09 (+0.82%)

Fundamental Rating

2

Taking everything into account, NXI scores 2 out of 10 in our fundamental rating. NXI was compared to 71 industry peers in the Real Estate Management & Development industry. Both the profitability and financial health of NXI have multiple concerns. NXI does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year NXI has reported negative net income.
NXI had a positive operating cash flow in the past year.
Of the past 5 years NXI 4 years were profitable.
In the past 5 years NXI always reported a positive cash flow from operatings.
NXI.PA Yearly Net Income VS EBIT VS OCF VS FCFNXI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

1.2 Ratios

With a Return On Assets value of -2.58%, NXI is not doing good in the industry: 60.56% of the companies in the same industry are doing better.
With a Return On Equity value of -8.58%, NXI is not doing good in the industry: 67.61% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -2.58%
ROE -8.58%
ROIC N/A
ROA(3y)0.44%
ROA(5y)1.29%
ROE(3y)2.37%
ROE(5y)6.1%
ROIC(3y)N/A
ROIC(5y)N/A
NXI.PA Yearly ROA, ROE, ROICNXI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

The Gross Margin of NXI (23.71%) is worse than 60.56% of its industry peers.
NXI's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for NXI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 23.71%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.27%
GM growth 5Y-6.55%
NXI.PA Yearly Profit, Operating, Gross MarginsNXI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

More info and screens

2

2. Health

2.1 Basic Checks

NXI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, NXI has more shares outstanding
Compared to 5 years ago, NXI has more shares outstanding
The debt/assets ratio for NXI is higher compared to a year ago.
NXI.PA Yearly Shares OutstandingNXI.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
NXI.PA Yearly Total Debt VS Total AssetsNXI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

NXI has an Altman-Z score of 0.99. This is a bad value and indicates that NXI is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.99, NXI perfoms like the industry average, outperforming 52.11% of the companies in the same industry.
NXI has a debt to FCF ratio of 10.36. This is a negative value and a sign of low solvency as NXI would need 10.36 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 10.36, NXI is in the better half of the industry, outperforming 78.87% of the companies in the same industry.
NXI has a Debt/Equity ratio of 0.87. This is a neutral value indicating NXI is somewhat dependend on debt financing.
NXI's Debt to Equity ratio of 0.87 is in line compared to the rest of the industry. NXI outperforms 46.48% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.87
Debt/FCF 10.36
Altman-Z 0.99
ROIC/WACCN/A
WACC2.92%
NXI.PA Yearly LT Debt VS Equity VS FCFNXI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.3 Liquidity

NXI has a Current Ratio of 1.35. This is a normal value and indicates that NXI is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of NXI (1.35) is worse than 60.56% of its industry peers.
NXI has a Quick Ratio of 1.35. This is a bad value and indicates that NXI is not financially healthy enough and could expect problems in meeting its short term obligations.
NXI has a Quick ratio (0.73) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.35
Quick Ratio 0.73
NXI.PA Yearly Current Assets VS Current LiabilitesNXI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

More info and screens

1

3. Growth

3.1 Past

The earnings per share for NXI have decreased strongly by -419.40% in the last year.
Looking at the last year, NXI shows a very negative growth in Revenue. The Revenue has decreased by -16.43% in the last year.
The Revenue has been decreasing by -4.52% on average over the past years.
EPS 1Y (TTM)-419.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-214.9%
Revenue 1Y (TTM)-16.43%
Revenue growth 3Y-9.31%
Revenue growth 5Y-4.52%
Sales Q2Q%-17.67%

3.2 Future

Based on estimates for the next years, NXI will show a very strong growth in Earnings Per Share. The EPS will grow by 30.16% on average per year.
NXI is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -4.44% yearly.
EPS Next Y16.57%
EPS Next 2Y42.57%
EPS Next 3Y30.16%
EPS Next 5YN/A
Revenue Next Year-19.56%
Revenue Next 2Y-8.51%
Revenue Next 3Y-4.44%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
NXI.PA Yearly Revenue VS EstimatesNXI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B
NXI.PA Yearly EPS VS EstimatesNXI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2 3

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NXI. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 259.31, the valuation of NXI can be described as expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as NXI.
NXI's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 34.04.
Industry RankSector Rank
PE N/A
Fwd PE 259.31
NXI.PA Price Earnings VS Forward Price EarningsNXI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100 150 200 250

4.2 Price Multiples

64.79% of the companies in the same industry are more expensive than NXI, based on the Enterprise Value to EBITDA ratio.
94.37% of the companies in the same industry are more expensive than NXI, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 3.18
EV/EBITDA 20.81
NXI.PA Per share dataNXI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40 50

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as NXI's earnings are expected to grow with 30.16% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.57%
EPS Next 3Y30.16%

More info and screens

6

5. Dividend

5.1 Amount

NXI has a Yearly Dividend Yield of 17.45%, which is a nice return.
Compared to an average industry Dividend Yield of 7.87, NXI pays a better dividend. On top of this NXI pays more dividend than 94.37% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.40, NXI pays a better dividend.
Industry RankSector Rank
Dividend Yield 17.45%

5.2 History

The dividend of NXI decreases each year by -0.01%.
Dividend Growth(5Y)-0.01%
Div Incr Years0
Div Non Decr Years0
NXI.PA Yearly Dividends per shareNXI.PA Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 0.5 1 1.5 2 2.5

5.3 Sustainability

DP0%
EPS Next 2Y42.57%
EPS Next 3Y30.16%
NXI.PA Yearly Income VS Free CF VS DividendNXI.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

More info and screens

NEXITY

EPA:NXI (8/8/2025, 7:00:00 PM)

11

+0.09 (+0.82%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)07-24 2025-07-24
Earnings (Next)10-23 2025-10-23
Inst Owners35.04%
Inst Owner ChangeN/A
Ins Owners0.13%
Ins Owner ChangeN/A
Market Cap617.43M
Analysts78
Price Target11.65 (5.91%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 17.45%
Yearly Dividend2.51
Dividend Growth(5Y)-0.01%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-3.93%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.49%
Revenue NY rev (3m)-5.52%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 259.31
P/S 0.2
P/FCF 3.18
P/OCF 2.56
P/B 0.35
P/tB 1.19
EV/EBITDA 20.81
EPS(TTM)-2.72
EYN/A
EPS(NY)0.04
Fwd EY0.39%
FCF(TTM)3.46
FCFY31.45%
OCF(TTM)4.3
OCFY39.11%
SpS54.4
BVpS31.48
TBVpS9.23
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.58%
ROE -8.58%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 23.71%
FCFM 6.36%
ROA(3y)0.44%
ROA(5y)1.29%
ROE(3y)2.37%
ROE(5y)6.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.27%
GM growth 5Y-6.55%
F-Score4
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.87
Debt/FCF 10.36
Debt/EBITDA 15.31
Cap/Depr 26.75%
Cap/Sales 1.55%
Interest Coverage N/A
Cash Conversion 240.19%
Profit Quality N/A
Current Ratio 1.35
Quick Ratio 0.73
Altman-Z 0.99
F-Score4
WACC2.92%
ROIC/WACCN/A
Cap/Depr(3y)30.71%
Cap/Depr(5y)31.16%
Cap/Sales(3y)1.5%
Cap/Sales(5y)1.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-419.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-214.9%
EPS Next Y16.57%
EPS Next 2Y42.57%
EPS Next 3Y30.16%
EPS Next 5YN/A
Revenue 1Y (TTM)-16.43%
Revenue growth 3Y-9.31%
Revenue growth 5Y-4.52%
Sales Q2Q%-17.67%
Revenue Next Year-19.56%
Revenue Next 2Y-8.51%
Revenue Next 3Y-4.44%
Revenue Next 5YN/A
EBIT growth 1Y-137.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year143.99%
EBIT Next 3Y55.17%
EBIT Next 5YN/A
FCF growth 1Y-25.42%
FCF growth 3Y62.63%
FCF growth 5Y-7.99%
OCF growth 1Y-26.5%
OCF growth 3Y33.4%
OCF growth 5Y-7.85%